A 6-year-old child with β-thalassemia major is receiving regular blood transfusions. The child's parents express concern about the frequent transfusions and ask about alternative treatments. What is the most appropriate nursing intervention?
The nurse is caring for a pediatric patient with β-thalassemia major who requires ongoing management.
1Reassure the parents that blood transfusions are the only treatment option available
2Educate the parents about iron chelation therapy and its importance in preventing complications✓ 정답
3Suggest that the parents consider reducing the frequency of transfusions to minimize risks
4Recommend immediate consultation with a social worker for family support services
해설
Iron chelation therapy is essential for children with β-thalassemia major who receive regular blood transfusions to prevent iron overload complications.
β-thalassemia major is a severe inherited hemoglobin disorder that requires comprehensive nursing care and family education. Children with this condition have a defect in β-globin chain production, leading to severe anemia, and regular blood transfusions are essential for survival.
The most appropriate nursing intervention is parent education on iron chelation therapy. This is because repeated transfusions inevitably lead to iron overload (hemosiderosis). Each unit of blood contains approximately 200-250 mg of iron, and the human body has no natural mechanism to excrete excess iron. Without proper chelation therapy, iron accumulates in vital organs such as the heart, liver, and endocrine glands, potentially causing fatal complications like cardiomyopathy, cirrhosis, and endocrine dysfunction.
Iron chelation therapy using medications such as deferoxamine, deferasirox, and deferiprone removes excess iron from the body and prevents organ damage. This treatment is typically started when serum ferritin levels exceed 1000 ng/mL or after 10-20 transfusions. Parents need comprehensive education on the importance of chelation therapy, potential side effects, and monitoring requirements.
Effective nursing management of β-thalassemia major includes monitoring transfusion reactions, assessing for signs of iron overload, supporting family coping, and providing ongoing education on disease management. Nurses play a crucial role in helping families understand the complex treatment regimen and recognize the importance of long-term adherence to both transfusions and chelation therapy.
Understanding the Parental Concern
When parents of a child with β-thalassemia major ask about alternatives to frequent transfusions, they are often expressing the emotional and social burden identified in chronic care management. Research highlights that caring for a child with thalassemia major significantly impacts parental quality of life due to the relentless treatment schedule and economic strain [1]. As the nurse, your role is not simply to dismiss this concern but to provide education that empowers them within the reality of the standard of care.
Why Blood Transfusions Remain Essential
In β-thalassemia major, a genetic defect causes absent or severely reduced synthesis of the beta-globin chains of hemoglobin. This leads to ineffective erythropoiesis and severe, life-threatening anemia. Regular blood transfusions are the cornerstone of management to suppress the body's ineffective red blood cell production, maintain adequate hemoglobin levels for growth and development, and prevent the skeletal deformities and organomegaly that result from marrow expansion. Simply reducing the frequency of transfusions to minimize risks would expose the child to the primary pathophysiology of the disease and is not a safe alternative.
The Critical Link: Iron Chelation Therapy
The most appropriate nursing intervention is to educate the parents about iron chelation therapy. This directly addresses an unspoken concern that often underlies questions about transfusion frequency: the fear of iron overload. Each unit of transfused blood introduces a massive amount of iron that the body has no physiological mechanism to excrete. Without intervention, this iron accumulates in the heart, liver, and endocrine glands, leading to fatal complications such as heart failure, cirrhosis, and diabetes. This is where the concept of a dedicated thalassemia day care service becomes vital, as it integrates medical management with social support to ensure adherence to both transfusion and chelation regimens [2]. By educating parents that iron chelation therapy is the specific, evidence-based intervention designed to manage the primary risk of transfusions, you transform their fear into actionable knowledge. You explain that the treatment plan is a two-part strategy: transfusions to correct the anemia, and chelation to remove the toxic iron. This holistic approach is fundamental to improving the quality of life for both the child and the family, as effective chelation prevents the long-term organ damage that severely impacts well-being .
Analyzing the Incorrect Options
- Option 1 is incorrect and dismissive. It shuts down communication and fails to provide the education that is a core nursing responsibility. It also ignores the existence of curative therapies like hematopoietic stem cell transplantation, which, while not a first-line alternative for all, means transfusions are not the only option.
- Option 3 is dangerous. A nurse should never independently suggest altering a life-sustaining treatment protocol. Reducing transfusion frequency without a corresponding medical order would lead to severe anemia and its complications.
- Option 4 is a supportive but secondary action. While psychosocial support is crucial for managing the chronic burden of the disease [1], it does not address the immediate clinical question about treatment alternatives. The priority is to first provide the education that can alleviate the core medical worry driving the parents' question.
References (research sources)
[1]
Nursing interventions for improving quality of life among parents with major Thalassemic children: a scoping review.Research articleMardhiyah A, Yosep I, Hendrawati S, Rakhmawati W, Khoirunnisa K, Eriyani T, Hikmat R. (2025) · DOI: 10.1186/s12912-025-02994-1
[2]
Impact of Dedicated Thalassemia Day Care Services: Pediatric Hematologist's Perspective.Research articleKhurana R, Kanvinde P, Ganatra P, Bodhanwala M, Aggarwal B, Mudaliar S. (2025) · DOI: 10.1007/s12288-024-01817-8
Transfusion & Chelation in ThalassemiaAddressing Parental Concerns About Treatment
When parents ask about alternatives to transfusions, they often fear the complications of therapy itself. The key is to educate, not dismiss. The standard of care for β-thalassemia major is a two-part regimen: regular transfusions to suppress ineffective erythropoiesis and iron chelation therapy to manage the resulting iron overload.
Initiate chelation therapy when serum ferritin approaches 1,000 ng/mL or after 10-20 transfusions. Common first-line oral chelators like deferasirox are often preferred for pediatric patients to improve adherence over continuous subcutaneous deferoxamine infusions.
Caution
Never reduce transfusion frequency to mitigate risks. Inadequate transfusion leads to severe anemia, marrow expansion with facial and skeletal deformities, and hepatosplenomegaly. The goal is to maintain a pre-transfusion hemoglobin of 9.5-10.5 g/dL.
β-thalassemia major — A genetic blood disorder causing absent or severely reduced beta-globin chain synthesis, leading to life-threatening anemia requiring regular blood transfusions.
Iron chelation therapy — Pharmacological treatment to bind and remove excess iron from the body, preventing organ damage from iron overload caused by chronic blood transfusions.
Ineffective erythropoiesis — The production of defective red blood cells that are destroyed in the bone marrow before they mature, a hallmark of thalassemia major.
Hemosiderosis — The accumulation of iron in tissues, a major complication of long-term transfusion therapy that can lead to organ failure without chelation.